Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
444,806,861
-
Total 13F shares
-
100,000
-
Share change
-
-12,205
-
Total reported value
-
$3,000
-
Price per share
-
$0.03
-
Number of holders
-
1
-
Value change
-
-$1,000
-
Number of sells
-
1
Institutional Holders of PROVECTUS BIOPHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (PVCT) as of Q2 2017
As of 30 Jun 2017,
PROVECTUS BIOPHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (PVCT) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
100,000 shares.
The largest 1 holders included
HOME FEDERAL BANK OF TENNESSEE.
This page lists
1
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.